Description

6H-Pyrrolo(2,3-D)Pyrimidin-6-One, 5,7-Dihydro-7-Methyl-2-(Methyl(2-Phenylethyl)Amino)-, Monohydrochloride is a high-purity, complex heterocyclic compound primarily used as a key synthetic intermediate in advanced pharmaceutical research and development. This compound matters because it provides a critical building block for the synthesis of novel therapeutic agents, particularly in the fields of oncology and antiviral drug discovery. Pharmaceutical companies, contract research organizations (CROs), and fine chemical manufacturers need this material for developing new active pharmaceutical ingredients (APIs) and for process optimization studies.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the multi-step synthesis of targeted small-molecule drugs.
• Oncology Research: Used in the development of kinase inhibitors and other anti-cancer compounds targeting specific cellular pathways.
• Antiviral Drug Development: Acts as a scaffold for creating novel compounds with potential activity against various viruses.
• Biochemical Research: Employed in academic and industrial labs for studying enzyme inhibition and receptor-ligand interactions.
• Process Chemistry & Scale-Up: Utilized by process chemists to develop and optimize scalable, cost-effective synthetic routes for API manufacturing.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development and quality control in API production.

Basic Information

Product Name	6H-Pyrrolo(2,3-D)Pyrimidin-6-One, 5,7-Dihydro-7-Methyl-2-(Methyl(2-Phenylethyl)Amino)-, Monohydrochloride
CAS No.	122113-27-3
Molecular Formula	C₁₆H₂₁N₅O·HCl
Molecular Weight	335.83 g/mol (Free base: 299.37 g/mol)
Synonyms	7-Methyl-2-[(2-phenylethyl)(methyl)amino]-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one hydrochloride; 2-[(2-Phenylethyl)(methyl)amino]-7-methyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one monohydrochloride; 6H-Pyrrolo[2,3-d]pyrimidin-6-one, 5,7-dihydro-7-methyl-2-[methyl(2-phenylethyl)amino]-, monohydrochloride; A specific kinase inhibitor intermediate (proprietary code names may apply).
EINECS	Contact for details

Quality Control

Our 6H-Pyrrolo(2,3-D)Pyrimidin-6-One, 5,7-Dihydro-7-Methyl-2-(Methyl(2-Phenylethyl)Amino)-, Monohydrochloride is manufactured under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and tests for residual solvents and heavy metals to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) documenting all specifications are available upon request, and we can support custom purity grades to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a dry environment and away from direct light exposure to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	≤ 20 ppm
Assay (on dried basis)	97.0% - 102.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.